express shipping on all orders & free express shipping over AUD$150
Checkout: 0

Your Cart is Empty

USD
AUD
NZD
GBP
EUR
CAD
HKD
SGD
JPY

Do you suffer from plaque psoriasis? Have you considered participating in a research trial?

Do you suffer from plaque psoriasis? Have you considered participating in a research trial?

At Solbari we believe in raising awareness and giving back. We proudly support the Skin & Cancer Foundation Inc., and have an opportunity for people affected by psoriasis.

Psoriasis is a chronic skin condition which is represented by patches of abnormal skin. The affected areas of skin are typically reddish in colour, itchy, scaly and dry. Psoriasis can be localised or cover many skin areas in extreme cases.

There are five different types of psoriasis but the most common type is called plaque psoriasis which accounts for 90 percent of cases. The areas of the body most commonly impacted by psoriasis include the back, scalp forearms and shins.

You can make a difference by participating in a clinical trial and work collectively with the Skin & Cancer Foundation Inc. team to find better solutions for complex skin issues.

Do you or someone you know suffer from plaque psoriasis?

The Skin & Cancer Foundation is seeking adults 18+ with a diagnosis of moderate to severe plaque psoriasis to participate in a 52 week research study.

To be eligible, participants must have psoriasis that covers 10% or more of their body surface area.

Participants will receive investigational study medication (active drug) or placebo (inactive drug).

Reimbursement for study-related expenses will be provided.

For more information visit:
https://www.skincancer.asn.au/page/103/current-clinical-trials

Facts:

  • Clinical Trials Manager Sarah Chivers is on hand to answer any questions you might have. Please call (03) 9623 9465.
  • The team consists of Sarah, Irena, Tracy, Dr. Natalie Wong and is led by A/Professor Peter Foley – expert in psoriasis treatment.
  • The trial runs for 52 weeks: you will be required to visit the S&CF on 5 occasions in the first 6-7 weeks and then every month until the conclusion of the trial.

For further information, please visit:
https://www.skincancer.asn.au/page/103/current-clinical-trials or contact the clinical trials team:

Dr Natalie Wong - telephone: (03) 9623 9400, email: nwong@skincancer.asn.au

Sarah Chivers - telephone: (03) 9623 9465, email: schivers@skincancer.asn.au

Solbari Sensitive Range

Solbari has developed a sensitive fabric range that caters to those with sensitive skin. Our Sensitive fabric is made from a blend of organic cotton & bamboo fibres that are super soft in texture, help regulate body temperature in warm conditions.

Solbari is the leading Australian sun protective clothing brand with customers in over 70 countries.

You can find out more about Solbari's certified UPF50+ sensitive range by clicking the blue links below:  
Women UPF50+ Sensitive Range
Men UPF50+ Sensitive Range



Also in Solbari Skin Health Blog

Which countries have the highest rates of skin cancer?
Which countries have the highest rates of skin cancer?

Australia is ranked 1st for melanoma incidence rates at 33.6 per 100,000 of population. This has equated to between 1,400 and 2,000 Australians dying from melanoma per annum in recent times.

Read more.

Read More
Why did we decide to launch a skin check app with SkinVision and why now?
Why did we decide to launch a skin check app with SkinVision and why now?

We understand that getting an appointment with a dermatologist or skin doctor can be challenging and expensive. 

We decided it would be great to bring the best early skin cancer detection technology direct to the Solbari global community. 

Read more.

Read More
What has been the impact of Covid-19 on Skin Cancer detection rates?
What has been the impact of Covid-19 on Skin Cancer detection rates?

The introduction of “lockdowns”, the restriction of movement and non-essential healthcare activities being suspended have had an impact on the diagnosis of cancer cases including skin cancer. 

Countries around the World are now evaluating the unintended consequences of Covid-19 restrictions on the diagnosis of cancer. Sadly, cancer related death rates are expected to increase over the coming years due to the delay in diagnosis.

Read More